Summary
Updated Aug 30, 2026
James A. Graf is Chief Financial Officer of NKGen Biotech, Inc. (NKGN). 1 SEC Form 4 filing on record, dated 10 December 2024.
Trading Pattern
InsiderAlpha's records for James A. Graf go back to 2024: 1 primary Form 4 filing, an average of 0.3 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who have reported open-market trades at the same companies as James A. Graf. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- CFIC-2015 NV Family Investments, LLC - $7.50M of NKGN open-market activity on record
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is James A. Graf?
James A. Graf is a corporate insider, tracked as Chief Financial Officer of NKGen Biotech, Inc. (NKGN). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did James A. Graf last file a Form 4?
The only primary Form 4 on record is dated 10 December 2024.
Where can I see all of James A. Graf's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow James A. Graf and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial